NY-ESTÉE-LAUDER
TOM FORD announced today that Dexter King has been appointed Senior Vice President, Global General Manager, TOM FORD BEAUTY. King will step into this role effective April 1, 2024 and continue reporting to Guillaume Jesel, President and CEO, TOM FORD and Luxury Business Development, The Estée Lauder Companies. King will also join The Estée Lauder Companies (NYSE:EL) Extended Executive Leadership Team.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240405576513/en/
Dexter King has been appointed Senior Vice President, Global General Manager, TOM FORD BEAUTY. (Photo: Business Wire)
King has been with TOM FORD BEAUTY for nine years, working in a number of key leadership roles including most recently as Senior Vice President (SVP), Global Marketing and Strategy, and prior to then as SVP, General Manager, International and Global Strategy. In close partnership with Jesel, under King’s leadership of strategy and International, the brand elevated key TOM FORD fragrances to the luxury tier, accelerated its channel strategy and achieved exceptional growth and share gains across key markets.
“Dexter’s multi-faceted leadership experience at TOM FORD BEAUTY has been instrumental in helping the brand achieve exceptional global growth,” said Jesel. “His deep understanding of luxury, the importance of aspirational local relevance, and his command of the strategic growth opportunities in the luxury sector make him well-suited to lead the continued global momentum of TOM FORD BEAUTY.”
In his new role, King will lead the TOM FORD BEAUTY team in all aspects of category, channel and geography strategic growth plans. He will focus on driving the brand’s luxury beauty positioning through world-class innovation across makeup, fragrance and skincare and continue to elevate the brand’s signature aspirational storytelling of modern luxury glamour and amplifying individual beauty.
Prior to TOM FORD BEAUTY, King worked in strategy and marketing roles, holding positions of increasing responsibility across companies including McKinsey & Company, Diageo, and Moët Hennessy. King holds a Master of Business Administration from The Fuqua School of Business at Duke University and a Bachelor of Arts in Economics from the University of Virginia.
About TOM FORD
TOM FORD IS A GLOBAL DESIGN HOUSE OFFERING EXCEPTIONAL LUXURY PRODUCTS ACROSS WOMEN’S AND MEN’S FASHION, ACCESSORIES, EYEWEAR AND BEAUTY. FOUNDED IN 2005 BY TOM FORD, TODAY THE BRAND HAS A PRESENCE IN MORE THAN 100 MARKETS GLOBALLY, AND IS WIDELY RECOGNIZED AS THE ARCHITECT OF LUXURY GLAMOUR. IN 2023, THE ESTÉE LAUDER COMPANIES BECAME THE SOLE OWNER OF THE TOM FORD BRAND AND ALL ITS INTELLECTUAL PROPERTY. IN APRIL 2023 PETER HAWKINGS WAS APPOINTED THE CREATIVE DIRECTOR OF TOM FORD.
About TOM FORD BEAUTY
TOM FORD IS A GLOBAL DESIGN HOUSE OFFERING EXCEPTIONAL LUXURY PRODUCTS ACROSS WOMEN’S AND MEN’S FASHION, ACCESSORIES, EYEWEAR AND BEAUTY. FOUNDED IN 2005 BY TOM FORD, TODAY THE BRAND HAS A PRESENCE IN MORE THAN 100 MARKETS GLOBALLY, AND IS WIDELY RECOGNIZED AS THE ARCHITECT OF LUXURY GLAMOUR. TOM FORD BEAUTY IS DESIGNED TO AMPLIFY INDIVIDUAL BEAUTY WITH A COLLECTION OF SUMPTUOUS COSMETICS, EXTRAORDINARY FRAGRANCES AND ADVANCED SKINCARE.
ELC-B
NYSE: EL
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240405576513/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Volante Technologies Customers Successfully Navigate Critical Regulatory Deadlines for EU SEPA Instant and Global SWIFT Cross-Border Payments16.12.2025 10:00:00 CET | Press release
PaaS leader ensures seamless migrations and uninterrupted payment operations Volante Technologies, the global leader in Payments as a Service (PaaS), today announced it has successfully upgraded its clients to meet the latest SEPA Instant Payments Regulation (IPR) and SWIFT SRG 2025 mandate, which came into effect October 9th and November 22nd, 2025, respectively. This announcement follows the major FedISO upgrade in July, which shifted trillions of dollars in payments to the new ISO 20022 messaging format. SEPA IPR is a significant European milestone, requiring payments to be made within 10 seconds and at any time of day, throughout the year. Adoption was mandatory and Eurozone banks were compelled to meet strict deadlines, with January 9th, 2025 the deadline for receiving incoming instant payments and October 9th the deadline for sending outgoing instant payments. The latest deadline impacted more than 700 banks across Europe, with non-compliance penalties reaching at least 10% of an
TreeFrog Therapeutics Announces Changes to Executive Committee With the Arrival of Mark Rothera as Chief Executive Officer & Board Member to Spearhead Next Phase of Growth16.12.2025 09:05:00 CET | Press release
TreeFrog Therapeutics, a French biotech focused on bringing regenerative medicine to millions through their proprietary cell technology, C-Stem™ is delighted to announce the appointment of skilled biotech leader, Mark Rothera, as Chief Executive Officer and Board member. He succeeds Frédéric Desdouits, who is stepping down after five years in the role. In the new leadership configuration, co-founders Kévin Alessandri and Maxime Feyeux will transition from daily operations to focus on their roles on the Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215145193/en/ Mark Rothera, CEO TreeFrog Therapeutics Elsy Boglioli, Chair of the Board of TreeFrog Therapeutics, commented “On behalf of the Board, we are delighted to welcome Mark to TreeFrog. His 30+ years of biopharma leadership, including most recently, three biotech CEO roles in gene therapy and biologics, will be invaluable as we advance our Parkinson’s and liver
RoslinCT and Ayrmid Ltd. Announce Expansion of Strategic Partnership to Manufacture Omisirge® (omidubicel-onlv) for Second FDA-Approved Indication in Severe Aplastic Anemia (SAA)16.12.2025 09:00:00 CET | Press release
RoslinCT is performing technology transfer and will support commercial manufacture of Omisirge® for an additional indication following successful clinical trialsOmisirge® now FDA-approved for an expanded patient population in hematologyRoslinCT continues to support and advance multiple cell therapy projects at its Hopkinton, MA facility Ayrmid Ltd., the parent company of Gamida Cell Inc., a pioneering cell therapy company transforming cells into powerful therapeutics, and RoslinCT, a global leader in cell and gene therapy contract development and manufacturing, today announced the expansion of their strategic partnership to include the execution of a commercial supply agreement to support production of Omisirge® (omidubicel-onlv). Following positive clinical trial results, Omisirge® has received FDA approval for a second indication, broadening its use in the treatment of hematology patients. Under the commercial supply agreement, RoslinCT will complete technology transfer and support c
Echoworx Secures FSQS-Netherlands Certification, Strengthening Trust in Financial Data Protection16.12.2025 07:00:00 CET | Press release
Leading encryption provider deepens commitment to European financial sector with rigorous new supplier qualification, building on existing UK & Ireland certification. Echoworx, a global leader in email and data encryption, proudly announces it has achieved Financial Services Qualification System (FSQS) registered supplier status for the Netherlands. This certification powerfully demonstrates Echoworx’s commitment to the highest standards of security and compliance. This achievement expands on the company’s existing FSQS certification for the UK and Ireland, secured in 2020. By successfully completing the rigorous qualification for the Netherlands, Echoworx reinforces its alignment with the stringent demands of the European financial market. The FSQS system, managed by Hellios, provides a single, reliable standard for vetting third-party suppliers, streamlining procurement for major banks and financial institutions. Think of FSQS as a high-security passport for technology partners. It p
Nippon Electric Glass to Start World’s First Mass Production of Low-Carbon Pharmaceutical Glass Tubing Using an All-Electric Furnace16.12.2025 03:00:00 CET | Press release
Nippon Electric Glass Co., Ltd. (NEG)(TOKYO:5214), a global leader in specialty glass headquartered in Otsu, Japan, announced it will begin the world’s first mass production of pharmaceutical-grade glass tubing using an all-electric melting furnace. Commercial production is scheduled to start in December 2025 at its subsidiary in Selangor, Malaysia. This breakthrough introduces a new manufacturing model for pharmaceutical packaging. By combining NEG’s proprietary all-electric melting technology with renewable energy, CO2 emissions from glass tubing production can be reduced by up to 90%*1 compared with conventional fossil-fuel combustion furnaces. This positions NEG as a major supplier capable of delivering both high-performance borosilicate glass and a significantly lower carbon footprint, directly addressing global sustainability demands from pharmaceutical companies and regulators. NEG is a leading global supplier of arsenic-free, environmentally friendly borosilicate glass tubing f
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom